Stocks to sell

Not too long ago, Boeing (NYSE:BA) stock was trading at more than $400. But since early 2019, BA stock has shed more than 50% of its value. The aerospace giant has been hit hard by multiple crises in the past year, significantly weakening its balance sheet and safety reputation. Source: Marco Menezes / Shutterstock.com Moreover,

Things appear to have gone from bad to worse for high-flying pharmaceutical company Moderna (NASDAQ:MRNA) stock, leaving shareholders reeling. Source: Ascannio / Shutterstock.com MRNA stock has cratered, dropping from $350 a share all the way down to $228. The steep fall came after the company reported disappointing quarterly results that shocked Wall Street and revised down

ContextLogic (NASDAQ:WISH) is set to announce its third-quarter earnings today under a new CFO. But there probably won’t be a lot to celebrate when the report is released. Ultimately, that means investing in WISH stock isn’t going to be worthwhile. Source: sdx15 / Shutterstock.com That said, ContextLogic will remain a popular choice for risk-tolerant retail

Old-school, traditional lenders now have a major threat, and its name is Upstart (NASDAQ:UPST). If you’re ready to join a revolution in the financial technology (fintech) market, I invite you to take a look at UPST stock. Source: Shutterstock However, you can put the stock on your watch list without actually buying it now. When an

InvestorPlace columnist Larry Ramer recently argued that Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) and Qualcomm (NASDAQ:QCOM) would become potential buyers of BlackBerry (NYSE:BB) once they become more familiar with the company’s QNX operating system. Ramer believes that’s a good reason to buy BB stock.     Source: Shutterstock “[C]ompanies can’t hire enough cybersecurity experts to protect themselves from ruinous hacks,

Facing potentially huge competition and generating gigantic losses, Affirm (NASDAQ:AFRM) stock has a poor outlook at this point. Source: Piotr Swat / Shutterstock.com Affirm has developed a Buy Now Pay Later (BNPL) offering. BNPL allows consumers to buy items now and pay for them in fixed installments. Sometimes Affirm’s BNPL factors in interest payments, while

Ocugen (NASDAQ:OCGN) stock didn’t move much on a recent announcement that it had applied to the FDA for a new emergency use authorization (EUA) for the Covaxin coronavirus vaccine. Source: shutterstock.com/PhotobyTawat This EUA is for people between the ages of two and 18, but the move is extremely unlikely to prevent OCGN stock from sliding in

With its massive price decline so far this year, is now the time to follow the crowd’s changing diagnosis on Teladoc (NYSE:TDOC)? Not so fast. TDOC stock may be down more than 25% year-to-date, and down about 50% from its all-time high of $308 per share. But despite this drop, and the fact it’s been trending

Palantir Technologies (NYSE:PLTR) hasn’t fully recovered since pulling back with the overall market in late September. But PLTR stock has still managed to slowly move higher in recent weeks. Source: Ascannio / Shutterstock.com To some extent, this uptrend makes sense. After all, the “story” behind this stock remains intact. The company has continued to post strong

Virgin Galactic (NYSE:SPCE) has been on a bad downward spiral. From a recent peak of $55.91 on June 25, SPCE stock is now near a low point of $19.55. However, despite this, don’t act on the urge just yet to bargain hunt in this stock. Source: rafapress / Shutterstock.com I forewarned investors that this could

Over the trailing year, a majority of my single-company opinions have been at least middle of the road for obvious reasons. Although I do have broader economic concerns, benchmark indices have proven resilient. So, my headline to consider exiting Novavax (NASDAQ:NVAX) stock might seem controversial. Source: Ascannio/Shutterstock.com However, I genuinely believe taking the green ink

If you’ve read my prior articles on Ocugen (NASDAQ:OCGN), you know full well my heavily bearish view about OCGN stock. What’s the story here? The company is trying to bring Covaxin, a Covid-19 vaccine candidate developed by India’s Bharat Biotech, to the U.S. and Canada. Source: shutterstock.com/PhotobyTawat So far, it’s made little progress obtaining Emergency

Microvision (NASDAQ:MVIS) specializes in providing a technology known as lidar, or light detection and ranging. There’s currently only a handful of ways to invest directly in the lidar market, and MVIS stock is one of them. Source: temp-64GTX/Shutterstock.com Just to give you a quick primer, lidar systems use laser beams to form a three-dimensional image of

Covid-19 vaccine giant Moderna (NASDAQ:MRNA) has been on a tear since the second quarter of 2020.  It has grown its top line by over 6,500% on a year-over-year basis due to rampant sales of its Covid-19 vaccine. As a consequence, it now trades at a whopping valuation hardly justified by its long-term outlook. The lack of

The only question left regarding Uber Technologies (NYSE:UBER) stock is: where’s the bottom? Source: NYCStock / Shutterstock.com At around $45.70 per share, the ride-hailing and food delivery company’s stock is well down from its 52-week high of $64.05. UBER stock has fallen 14% in the past six months, and the share price is now up

Peloton Interactive (NASDAQ:PTON) was a pandemic favorite. With gyms shut down and people stuck at home, they snapped up Peloton’s pricey internet-connected exercise bikes and treadmills. But in the spring, with gyms reopening and the outdoors beckoning, sales quickly dropped off. Then things got even worse for PTON stock. Source: JHVEPhoto / Shutterstock.com It put

Ocugen (NASDAQ:OCGN) is a stock that I continue to be wrong about. Over the past month, OCGN stock has gained more than 80%, greatly testing my patience. The stock has fallen from the $17 mark it reached this morning, but is still higher than I expected last month. Source: shutterstock.com/PhotobyTawat In my last article about

When it comes to Vinco Ventures (NASDAQ:BBIG) stock, investors continue to dig a larger hole for themselves rather than crafting a successful “mining operation” in the shares. Source: shutterstock.com/Postmodern Studio Let me explain. But first, let’s take a little trip back on memory lane to better understand how BBIG stock landed where it is today.

With the current headlines about the supply chain crisis, it may seem iffy to invest in retail stocks right now. Or is it? This latest issue, a side effect of the post-pandemic economic recovery, is affecting individual companies within the sector in different ways. Some retailers are well positioned to ride out this headwind. Others?

SmileDirectClub (NASDAQ:SDC) is an oral care company founded in 2014. Headquartered in Nashville, the company operates in the North America, Europe and Asia Pacific regions. Its primary offering is a clear aligner therapy treatment, but it also sells a variety of oral care products, such as whitening kits and gels, toothbrushes, toothpastes and water flossers. SDC